Skip to Content

Jim Bob Ward Named CEO of DATATRAK

Leadership transition complete   CLEVELAND, May 23 /PRNewswire/ DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced that interim CEO and founder of the software platform, Jim Bob Ward, has been named CEO and President. “Jim Bob’s influence as interim CEO has already had great positive impact,” said Alex Tabatabai, Chairman of the Board of Directors, DATATRAK. “Through his leadership, we have taken control of spending to report the first quarter of net income in two years.” The New Management Team of Julia Henderson (CFO), Tim Lyons (VP Operations) and Scott DeMell (VP Sales) are finalizing a company-wide review of product offerings, pricing, and contracting to formulate DATATRAK’s long-run strategic plan. The plan moving forward is being forged from recent meetings where Scott DeMell and Jim Bob met in person with our clients and prospects to focus on their needs, deepening our partnerships. “The feedback to our current solutions and vision has been positive and exciting. We look forward to expanding efficiencies in earlier stage clinical trials, advancing trial metrics, enhancing export standards, and more, to complete our upcoming CTMS offering at DIA,” said Jim Bob Ward, CEO and President, DATATRAK. The appointment of Mr. Ward to CEO and President completes the transition of the DATATRAK leadership team. Mr. Ward joins an experienced and dedicated team committed to delivering responsive software that simplifies the management of data for clinical trials. DATATRAK will introduce UX CTMS 360™, a robust enterprise solution that features turnkey configuration, online real-time reporting of all data across all studies on the platform, and a streamlined regulatory submission workflow. To find out more, visit DATATRAK online at Twitter: Jim Bob Ward named DATATRAK #CEO. Leadership transition is now complete   Join DATATRAK Thought Leaders:   About DATATRAK International, Inc. DATATRAK International is a worldwide technology and services company delivering unified dClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK’s Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Chicago, Illinois; Cleveland, Ohio; and Bryan, Texas.  For more information, visit Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management’s expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company’s report filed with the OTC Markets on April 8, 2016 announcing its results for the full-year period ended December 31, 2015. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.   Contacts: Sales: Scott DeMell   Employment Opportunities: Laura Stuebbe   Shareholders: Alex Tabatabai